| 25 May 2026 |
ARA-290 |
4.9 |
5mg |
5.3mg |
+5.8% |
96.64% |
Lab E |
| 25 May 2026 |
Test Propionate |
8.3 |
250mg/ml |
248.6mg/ml |
-0.6% |
97.29% |
Lab F |
| 25 May 2026 |
Thymosin Alpha-1 |
6.7 |
30mg |
26.5mg |
-11.5% |
95.20% |
Lab E |
| 24 May 2026 |
Boldenone Undecylenate (EQ) Raw |
7.3 |
1g |
1.0g |
+3.8% |
98.34% |
Lab D |
| 24 May 2026 |
Boldenone Undecylenate (EQ) Raw |
9.4 |
100g |
85.9g |
-14.1% |
98.44% |
Lab A |
| 24 May 2026 |
Testagen |
6.5 |
30mg |
26.4mg |
-12.1% |
96.41% |
Lab F |
| 24 May 2026 |
Vilon |
8.0 |
30mg |
27.8mg |
-7.2% |
98.75% |
Lab C |
| 24 May 2026 |
DHB (1-Test Cyp) Oral |
6.2 |
20mg |
22.9mg |
+14.4% |
99.60% |
Lab C |
| 24 May 2026 |
Equipoise (Boldenone Undecylenate) |
7.7 |
250mg/ml |
253.2mg/ml |
+1.3% |
97.96% |
Lab B |
| 24 May 2026 |
Cartalax |
9.4 |
5mg |
5.8mg |
+16.1% |
98.38% |
Lab F |
| 24 May 2026 |
Romosozumab |
6.8 |
30mg |
28.6mg |
-4.5% |
99.71% |
Lab A |
| 23 May 2026 |
Anadrol Oil |
6.9 |
250mg/ml |
254.5mg/ml |
+1.8% |
97.20% |
Lab A |
| 23 May 2026 |
Anavar (Oxandrolone) |
5.1 |
10mg |
9.0mg |
-9.9% |
99.66% |
Lab A |
| 23 May 2026 |
Cerebrolysin |
4.0 |
10mg |
8.5mg |
-14.9% |
95.39% |
Lab D |
| 23 May 2026 |
DHB (1-Test Cyp) Oral |
6.1 |
25mg |
30.7mg |
+22.6% |
95.74% |
Lab G |
| 23 May 2026 |
Dutasteride |
6.3 |
100mg |
92.7mg |
-7.3% |
98.67% |
Lab G |
| 21 May 2026 |
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 |
7.8 |
10g |
10.6g |
+6.4% |
97.75% |
Lab B |
| 21 May 2026 |
Sildenafil Raw |
6.7 |
5g |
4.6g |
-8.0% |
99.56% |
Lab D |
| 21 May 2026 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
6.2 |
20mg |
24.5mg |
+22.4% |
97.48% |
Lab D |
| 21 May 2026 |
Test Propionate |
8.0 |
200mg/ml |
181.1mg/ml |
-9.4% |
98.19% |
Lab A |
| 21 May 2026 |
Testosterone Cypionate Raw |
8.7 |
1g |
1.2g |
+19.2% |
99.02% |
Lab F |
| 21 May 2026 |
Lipo-B 216mg |
7.3 |
250mg/ml |
241.0mg/ml |
-3.6% |
96.28% |
Lab A |
| 21 May 2026 |
LL37 |
5.9 |
2mg |
1.9mg |
-6.7% |
97.77% |
Lab E |
| 21 May 2026 |
Testagen |
6.7 |
20mg |
24.5mg |
+22.7% |
98.71% |
Lab D |
| 20 May 2026 |
Sildenafil (Viagra) |
6.3 |
25mg |
23.4mg |
-6.6% |
98.41% |
Lab B |
| 20 May 2026 |
Super Shred |
6.2 |
100mg/ml |
117.7mg/ml |
+17.7% |
98.06% |
Lab E |
| 20 May 2026 |
Thymosin Alpha-1 |
6.6 |
10mg |
12.5mg |
+24.7% |
99.94% |
Lab D |
| 19 May 2026 |
Retatrutide |
7.7 |
10mg |
10.6mg |
+6.0% |
99.90% |
Lab E |
| 19 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.9 |
15mg |
16.5mg |
+10.3% |
97.32% |
Lab B |
| 19 May 2026 |
Super Shred |
5.5 |
100mg/ml |
108.4mg/ml |
+8.4% |
96.28% |
Lab C |
| 17 May 2026 |
ACE-031 |
4.7 |
2mg |
2.4mg |
+21.5% |
97.23% |
Lab G |
| 17 May 2026 |
Pancragen |
6.7 |
10mg |
8.7mg |
-12.9% |
95.29% |
Lab G |
| 29 Jan 2026 |
Tirzepatide |
8.0 |
10mg |
9.78mg |
-2.2% |
99.90% |
Lab E |
| 29 Jan 2026 |
Tirzepatide |
6.0 |
50mg |
56.2mg |
+12.4% |
99.90% |
Lab E |
| 29 Jan 2026 |
Anavar (Oxandrolone) |
4.3 |
20mg |
22.6mg |
+13.1% |
96.95% |
Lab F |
| 29 Jan 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
9.1 |
50mg |
45.0mg |
-10.0% |
96.45% |
Lab B |
| 29 Jan 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
5.7 |
30mg |
36.8mg |
+22.7% |
96.14% |
Lab F |
| 29 Jan 2026 |
LL37 |
7.7 |
15mg |
16.4mg |
+9.1% |
97.64% |
Lab G |
| 26 Jan 2026 |
Anadrol Oil |
7.7 |
250mg/ml |
229.5mg/ml |
-8.2% |
96.74% |
Lab G |
| 26 Jan 2026 |
Cerebrolysin |
4.0 |
10mg |
11.8mg |
+18.3% |
96.02% |
Lab C |
| 26 Jan 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
8.8 |
50mg |
60.9mg |
+21.7% |
99.41% |
Lab G |
| 26 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
9.0 |
30mg |
28.6mg |
-4.8% |
96.44% |
Lab A |
| 26 Jan 2026 |
Hyaluronic acid |
7.1 |
50mg |
48.2mg |
-3.6% |
96.53% |
Lab G |
| 26 Jan 2026 |
Thymosin Alpha-1 |
5.7 |
2mg |
2.3mg |
+13.7% |
97.73% |
Lab D |
| 19 Jan 2026 |
Tirzepatide |
8.0 |
15mg |
15.6mg |
+4.0% |
99.95% |
Lab E |
| 19 Jan 2026 |
ACE-031 |
4.3 |
10mg |
10.9mg |
+9.2% |
99.29% |
Lab G |
| 19 Jan 2026 |
Dutasteride |
6.9 |
25mg |
23.5mg |
-5.8% |
98.59% |
Lab B |
| 19 Jan 2026 |
Oxymetholone (Anadrol) Raw |
8.6 |
10g |
11.1g |
+10.9% |
95.17% |
Lab B |
| 15 Jan 2026 |
Tirzepatide |
4.8 |
100mg |
117.8mg |
+17.8% |
99.70% |
Lab G |
| 15 Jan 2026 |
Retatrutide |
7.5 |
20mg |
19.7mg |
-1.5% |
99.70% |
Lab G |
| 15 Jan 2026 |
Tirzepatide |
5.4 |
10mg |
11.5mg |
+15.0% |
99.80% |
Lab G |
| 9 Jan 2026 |
Sildenafil Raw |
8.3 |
1g |
1.2g |
+15.5% |
96.75% |
Lab D |
| 9 Jan 2026 |
Super Shred |
5.5 |
100mg/ml |
97.4mg/ml |
-2.6% |
96.05% |
Lab C |
| 7 Jan 2026 |
ARA-290 |
4.2 |
30mg |
36.5mg |
+21.5% |
96.08% |
Lab G |
| 7 Jan 2026 |
GHRP-2 Acetate |
6.6 |
5mg |
5.1mg |
+1.2% |
97.04% |
Lab C |
| 7 Jan 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
7.1 |
5mg |
6.0mg |
+19.5% |
95.51% |
Lab F |
| 7 Jan 2026 |
HMG |
7.3 |
2mg |
2.1mg |
+4.5% |
95.12% |
Lab D |
| 7 Jan 2026 |
Pancragen |
7.2 |
15mg |
17.3mg |
+15.5% |
97.29% |
Lab A |
| 7 Jan 2026 |
Testosterone Phenylpropionate Raw |
4.1 |
5g |
5.1g |
+2.2% |
95.45% |
Lab G |
| 7 Jan 2026 |
Testosterone Phenylpropionate Raw |
6.8 |
100g |
118.1g |
+18.1% |
98.88% |
Lab D |
| 7 Jan 2026 |
Testosterone Phenylpropionate Raw |
6.2 |
500g |
551.7g |
+10.3% |
96.36% |
Lab D |
| 6 Jan 2026 |
ACE-031 |
5.5 |
30mg |
30.5mg |
+1.8% |
97.63% |
Lab D |
| 6 Jan 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
4.0 |
10mg |
12.5mg |
+24.8% |
96.72% |
Lab E |
| 6 Jan 2026 |
Oxymetholone (Anadrol) Raw |
9.2 |
10g |
12.4g |
+24.2% |
97.52% |
Lab G |
| 6 Jan 2026 |
Testosterone Cypionate Raw |
6.9 |
5g |
4.9g |
-1.2% |
97.58% |
Lab B |
| 29 Dec 2025 |
ARA-290 |
5.1 |
5mg |
4.9mg |
-2.2% |
98.56% |
Lab D |
| 12 Dec 2025 |
BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 |
10.0 |
100g |
118.1g |
+18.1% |
99.84% |
Lab D |
| 12 Dec 2025 |
Vilon |
5.7 |
2mg |
1.7mg |
-13.2% |
96.47% |
Lab G |
| 5 Dec 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.6 |
20mg |
19.2mg |
-3.8% |
97.13% |
Lab F |
| 5 Dec 2025 |
Oxymetholone (Anadrol) Raw |
10.0 |
5g |
5.4g |
+8.1% |
96.66% |
Lab A |
| 5 Dec 2025 |
Tesamorelin 11mg + Ipamorelin 6mg Blend |
5.3 |
10mg |
10.9mg |
+8.9% |
97.01% |
Lab B |
| 5 Dec 2025 |
Test Propionate |
6.4 |
200mg/ml |
207.0mg/ml |
+3.5% |
95.98% |
Lab F |
| 23 Nov 2025 |
Anadrol Oil |
6.9 |
200mg/ml |
176.5mg/ml |
-11.8% |
99.64% |
Lab F |
| 17 Nov 2025 |
DHB (1-Test Cyp) Oral |
7.8 |
20mg |
20.7mg |
+3.4% |
96.47% |
Lab G |
| 17 Nov 2025 |
HMG |
6.7 |
50mg |
58.0mg |
+15.9% |
96.60% |
Lab E |
| 17 Nov 2025 |
Lipo-B 216mg |
7.8 |
250mg/ml |
241.2mg/ml |
-3.5% |
98.43% |
Lab C |
| 17 Nov 2025 |
Sildenafil (Viagra) |
7.4 |
10mg |
12.3mg |
+22.5% |
95.55% |
Lab G |
| 17 Nov 2025 |
Testagen |
5.0 |
5mg |
4.5mg |
-10.0% |
95.42% |
Lab A |
| 5 Nov 2025 |
Equipoise (Boldenone Undecylenate) |
5.8 |
250mg/ml |
244.2mg/ml |
-2.3% |
99.96% |
Lab C |
| 5 Nov 2025 |
Pancragen |
4.7 |
10mg |
9.4mg |
-5.5% |
99.21% |
Lab C |
| 4 Nov 2025 |
GHRP-2 Acetate |
6.8 |
20mg |
23.7mg |
+18.3% |
95.23% |
Lab D |
| 4 Nov 2025 |
Selank 10mg + Semax 10mg Blend |
7.4 |
5mg |
5.5mg |
+9.8% |
98.12% |
Lab E |
| 9 Oct 2025 |
Anavar (Oxandrolone) |
4.1 |
100mg |
103.2mg |
+3.2% |
99.29% |
Lab F |
| 9 Oct 2025 |
L-Carnitine 500mg |
5.1 |
100mg/ml |
88.2mg/ml |
-11.8% |
95.21% |
Lab D |
| 9 Oct 2025 |
Sildenafil (Viagra) |
5.2 |
100mg |
124.7mg |
+24.7% |
97.22% |
Lab E |
| 3 Oct 2025 |
Vilon |
8.1 |
10mg |
12.4mg |
+24.3% |
99.40% |
Lab G |